41/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0. Gray context columns never affect the score. CEO quarterly pay is the explicitly marked annual ÷ 4 estimate.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly. Unavailable evidence scores 0 only in Win/Lose columns; gray columns award no points.
| Quarter | Total return | Revenue growth | EPS growth | Net marginNon-scoring | Trailing P/ENon-scoring | Price/bookNon-scoring | CEO quarterly payNon-scoring | Implied DilutionNon-scoring | Implied BuybackNon-scoring |
|---|---|---|---|---|---|---|---|---|---|
| 2026-Q22/3 |
LoseCHRD / S&P -18.90% / 15.20% |
WinCHRD / S&P 19.23% / 15.00% |
WinCHRD / S&P 258.17% / 50.40% |
Non-scoringCHRD / S&P 13.42% / 15.70% | Non-scoringCHRD / S&P 7.44 / 28.47 | Non-scoringCHRD / S&P 0.75 / S&P unavailable | Non-scoringCHRD / S&P CHRD unavailable / S&P unavailable | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.36b |
| 2026-Q11/3 |
WinCHRD / S&P 54.99% / -4.33% |
LoseCHRD / S&P -0.99% / 11.30% |
LoseCHRD / S&P -107.58% / 27.70% |
Non-scoringCHRD / S&P -1.25% / 14.80% | Non-scoringCHRD / S&P CHRD unavailable / 25.43 | Non-scoringCHRD / S&P 0.99 / S&P unavailable | Non-scoringCHRD / S&P CHRD unavailable / S&P unavailable | Non-scoringCHRD / S&P CHRD unavailable / $0.27b | Non-scoringCHRD / S&P CHRD unavailable / $0.00b |
| 2025-Q40/3 |
LoseCHRD / S&P -5.38% / 2.65% |
LoseCHRD / S&P -7.12% / 9.00% |
LoseCHRD / S&P -96.23% / 13.40% |
Non-scoringCHRD / S&P 0.91% / 13.20% | Non-scoringCHRD / S&P 118.35 / 28.48 | Non-scoringCHRD / S&P 0.65 / 5.39 | Non-scoringCHRD / S&P CHRD unavailable / $4.42m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.20b |
| 2025-Q31/3 |
LoseCHRD / S&P 3.92% / 8.12% |
WinCHRD / S&P 8.43% / 4.61% |
LoseCHRD / S&P -85.46% / 13.45% |
Non-scoringCHRD / S&P 3.31% / 11.78% | Non-scoringCHRD / S&P 33.11 / 28.13 | Non-scoringCHRD / S&P 0.70 / 5.27 | Non-scoringCHRD / S&P CHRD unavailable / $4.42m | Non-scoringCHRD / S&P CHRD unavailable / $0.11b | Non-scoringCHRD / S&P CHRD unavailable / $0.00b |
| 2025-Q21/3 |
LoseCHRD / S&P -12.88% / 10.94% |
WinCHRD / S&P 19.55% / 4.83% |
LoseCHRD / S&P -79.84% / 10.63% |
Non-scoringCHRD / S&P 5.02% / 11.45% | Non-scoringCHRD / S&P 21.00 / 27.10 | Non-scoringCHRD / S&P 0.69 / 5.01 | Non-scoringCHRD / S&P CHRD unavailable / $4.42m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.23b |
| 2025-Q12/3 |
WinCHRD / S&P -2.37% / -4.27% |
WinCHRD / S&P 31.71% / 4.98% |
LoseCHRD / S&P -28.90% / 10.57% |
Non-scoringCHRD / S&P 16.15% / 11.39% | Non-scoringCHRD / S&P 7.55 / 26.23 | Non-scoringCHRD / S&P 0.76 / 4.69 | Non-scoringCHRD / S&P CHRD unavailable / $4.42m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.10b |
| 2024-Q41/3 |
LoseCHRD / S&P -9.20% / 2.41% |
WinCHRD / S&P 34.76% / 5.25% |
LoseCHRD / S&P -31.40% / 6.15% |
Non-scoringCHRD / S&P 16.16% / 11.29% | Non-scoringCHRD / S&P 8.28 / 28.60 | Non-scoringCHRD / S&P 0.81 / 4.99 | Non-scoringCHRD / S&P CHRD unavailable / $4.28m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.08b |
| 2024-Q31/3 |
LoseCHRD / S&P -21.01% / 5.89% |
WinCHRD / S&P 20.61% / 5.89% |
LoseCHRD / S&P -12.18% / 6.11% |
Non-scoringCHRD / S&P 19.74% / 10.87% | Non-scoringCHRD / S&P 8.52 / 28.09 | Non-scoringCHRD / S&P 0.91 / 4.94 | Non-scoringCHRD / S&P CHRD unavailable / $4.28m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.21b |
| 2024-Q21/3 |
LoseCHRD / S&P -4.38% / 4.28% |
WinCHRD / S&P 10.49% / 5.38% |
LoseCHRD / S&P -45.45% / 5.12% |
Non-scoringCHRD / S&P 20.83% / 10.85% | Non-scoringCHRD / S&P 11.30 / 27.64 | Non-scoringCHRD / S&P 1.18 / 4.79 | Non-scoringCHRD / S&P CHRD unavailable / $4.28m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.36b |
| 2024-Q10/3 |
LoseCHRD / S&P 9.39% / 10.56% |
LoseCHRD / S&P 5.01% / 5.71% |
LoseCHRD / S&P -45.41% / 5.59% |
Non-scoringCHRD / S&P 22.67% / 10.81% | Non-scoringCHRD / S&P 8.00 / 27.02 | Non-scoringCHRD / S&P 1.46 / 4.71 | Non-scoringCHRD / S&P CHRD unavailable / $4.28m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.12b |
| 2023-Q41/3 |
LoseCHRD / S&P 4.17% / 11.69% |
WinCHRD / S&P 6.85% / 6.81% |
LoseCHRD / S&P -58.19% / 7.78% |
Non-scoringCHRD / S&P 26.27% / 11.19% | Non-scoringCHRD / S&P 6.70 / 24.35 | Non-scoringCHRD / S&P 1.35 / 4.31 | Non-scoringCHRD / S&P CHRD unavailable / $4.08m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.01b |
| 2023-Q32/3 |
WinCHRD / S&P 6.29% / -3.27% |
WinCHRD / S&P 25.21% / 7.52% |
LoseCHRD / S&P -63.87% / -5.03% |
Non-scoringCHRD / S&P 27.86% / 10.84% | Non-scoringCHRD / S&P 6.10 / 23.93 | Non-scoringCHRD / S&P 1.36 / 3.98 | Non-scoringCHRD / S&P CHRD unavailable / $4.08m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.24b |
| 2023-Q22/3 |
WinCHRD / S&P 16.90% / 8.74% |
WinCHRD / S&P 72.02% / 9.50% |
LoseCHRD / S&P -14.68% / -8.57% |
Non-scoringCHRD / S&P 44.17% / 10.88% | Non-scoringCHRD / S&P 3.59 / 24.01 | Non-scoringCHRD / S&P 1.32 / 4.19 | Non-scoringCHRD / S&P CHRD unavailable / $4.08m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.17b |
| 2023-Q12/3 |
LoseCHRD / S&P 1.78% / 7.50% |
WinCHRD / S&P 103.95% / 10.77% |
WinCHRD / S&P -6.08% / -15.69% |
Non-scoringCHRD / S&P 43.37% / 10.82% | Non-scoringCHRD / S&P 3.31 / 22.66 | Non-scoringCHRD / S&P 1.17 / 3.93 | Non-scoringCHRD / S&P CHRD unavailable / $4.08m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.13b |
| 2022-Q42/3 |
LoseCHRD / S&P 2.38% / 7.56% |
WinCHRD / S&P 130.82% / 11.88% |
WinCHRD / S&P 268.02% / -17.99% |
Non-scoringCHRD / S&P 50.90% / 11.09% | Non-scoringCHRD / S&P 3.06 / 22.65 | Non-scoringCHRD / S&P 1.21 / 3.75 | Non-scoringCHRD / S&P CHRD unavailable / $3.70m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.15b |
| 2022-Q31/3 |
WinCHRD / S&P 29.42% / -4.88% |
LoseCHRD / S&P CHRD unavailable / 13.47% |
LoseCHRD / S&P CHRD unavailable / -1.41% |
Non-scoringCHRD / S&P 53.81% / 12.28% | Non-scoringCHRD / S&P 3.35 / 20.58 | Non-scoringCHRD / S&P 1.27 / 3.60 | Non-scoringCHRD / S&P CHRD unavailable / $3.70m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.17b |
| 2022-Q21/3 |
WinCHRD / S&P -14.94% / -16.10% |
LoseCHRD / S&P CHRD unavailable / 13.71% |
LoseCHRD / S&P CHRD unavailable / 11.04% |
Non-scoringCHRD / S&P 38.01% / 13.03% | Non-scoringCHRD / S&P 2.70 / 20.28 | Non-scoringCHRD / S&P 2.00 / 3.78 | Non-scoringCHRD / S&P CHRD unavailable / $3.70m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.17b |
| 2022-Q11/3 |
WinCHRD / S&P 19.01% / -4.60% |
LoseCHRD / S&P CHRD unavailable / 15.97% |
LoseCHRD / S&P CHRD unavailable / 42.23% |
Non-scoringCHRD / S&P 43.47% / 14.22% | Non-scoringCHRD / S&P 3.45 / 22.19 | Non-scoringCHRD / S&P 1.99 / 4.51 | Non-scoringCHRD / S&P CHRD unavailable / $3.70m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.20b |
| 2021-Q41/3 |
WinCHRD / S&P 27.22% / 11.03% |
LoseCHRD / S&P CHRD unavailable / 15.00% |
LoseCHRD / S&P CHRD unavailable / 96.40% |
Non-scoringCHRD / S&P 20.23% / 15.13% | Non-scoringCHRD / S&P 7.60 / 23.63 | Non-scoringCHRD / S&P 2.35 / 4.73 | Non-scoringCHRD / S&P CHRD unavailable / $3.63m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.13b |
| 2021-Q31/3 |
WinCHRD / S&P 3.36% / 0.58% |
LoseCHRD / S&P CHRD unavailable / 10.77% |
LoseCHRD / S&P CHRD unavailable / 69.42% |
Non-scoringCHRD / S&P CHRD unavailable / 14.13% | Non-scoringCHRD / S&P CHRD unavailable / 25.35 | Non-scoringCHRD / S&P 2.19 / 4.38 | Non-scoringCHRD / S&P CHRD unavailable / $3.63m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.19b |
| 2021-Q21/3 |
WinCHRD / S&P 70.17% / 8.55% |
LoseCHRD / S&P CHRD unavailable / 6.58% |
LoseCHRD / S&P CHRD unavailable / 51.81% |
Non-scoringCHRD / S&P CHRD unavailable / 13.34% | Non-scoringCHRD / S&P CHRD unavailable / 26.70 | Non-scoringCHRD / S&P 2.39 / 4.43 | Non-scoringCHRD / S&P CHRD unavailable / $3.63m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.11b |
| 2021-Q11/3 |
WinCHRD / S&P 61.28% / 6.17% |
LoseCHRD / S&P CHRD unavailable / -1.06% |
LoseCHRD / S&P CHRD unavailable / 7.39% |
Non-scoringCHRD / S&P CHRD unavailable / 11.60% | Non-scoringCHRD / S&P CHRD unavailable / 30.50 | Non-scoringCHRD / S&P 1.38 / 4.23 | Non-scoringCHRD / S&P CHRD unavailable / $3.63m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.10b |
| 2020-Q41/3 |
WinCHRD / S&P 13135.70% / 12.15% |
LoseCHRD / S&P CHRD unavailable / -3.72% |
LoseCHRD / S&P CHRD unavailable / -33.42% |
Non-scoringCHRD / S&P CHRD unavailable / 8.86% | Non-scoringCHRD / S&P CHRD unavailable / 39.26 | Non-scoringCHRD / S&P 0.81 / 4.05 | Non-scoringCHRD / S&P CHRD unavailable / $3.17m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.01b |
| 2020-Q30/3 |
LoseCHRD / S&P -62.67% / 8.93% |
LoseCHRD / S&P -46.60% / -2.04% |
LoseCHRD / S&P -2657.14% / -27.10% |
Non-scoringCHRD / S&P -388.31% / 9.24% | Non-scoringCHRD / S&P CHRD unavailable / 34.27 | Non-scoringCHRD / S&P CHRD unavailable / 3.65 | Non-scoringCHRD / S&P CHRD unavailable / $3.17m | Non-scoringCHRD / S&P CHRD unavailable / $0.02b | Non-scoringCHRD / S&P CHRD unavailable / $0.00b |
| 2020-Q21/3 |
WinCHRD / S&P 114.29% / 20.54% |
LoseCHRD / S&P -42.01% / -0.46% |
LoseCHRD / S&P -2112.86% / -27.11% |
Non-scoringCHRD / S&P -323.23% / 9.37% | Non-scoringCHRD / S&P CHRD unavailable / 31.29 | Non-scoringCHRD / S&P CHRD unavailable / 3.44 | Non-scoringCHRD / S&P CHRD unavailable / $3.17m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.03b |
| 2020-Q11/3 |
LoseCHRD / S&P -89.26% / -19.60% |
LoseCHRD / S&P -28.10% / 3.47% |
WinCHRD / S&P 2869.57% / -14.75% |
Non-scoringCHRD / S&P -248.11% / 10.68% | Non-scoringCHRD / S&P CHRD unavailable / 22.80 | Non-scoringCHRD / S&P CHRD unavailable / 2.92 | Non-scoringCHRD / S&P CHRD unavailable / $3.17m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.05b |
| 2019-Q41/3 |
LoseCHRD / S&P -5.78% / 9.07% |
LoseCHRD / S&P -16.85% / 5.36% |
WinCHRD / S&P 366.67% / 2.99% |
Non-scoringCHRD / S&P -6.64% / 12.81% | Non-scoringCHRD / S&P CHRD unavailable / 22.78 | Non-scoringCHRD / S&P 0.29 / 3.53 | Non-scoringCHRD / S&P CHRD unavailable / $3.08m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.05b |
| 2019-Q30/3 |
LoseCHRD / S&P -39.08% / 1.70% |
LoseCHRD / S&P 0.72% / 5.02% |
LoseCHRD / S&P -286.67% / 0.21% |
Non-scoringCHRD / S&P 7.78% / 12.41% | Non-scoringCHRD / S&P 6.53 / 22.44 | Non-scoringCHRD / S&P 0.30 / 3.30 | Non-scoringCHRD / S&P CHRD unavailable / $3.08m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.09b |
| 2019-Q21/3 |
LoseCHRD / S&P -5.96% / 4.30% |
WinCHRD / S&P 32.04% / 6.64% |
LoseCHRD / S&P -202.94% / 8.65% |
Non-scoringCHRD / S&P 8.92% / 12.79% | Non-scoringCHRD / S&P 8.62 / 21.37 | Non-scoringCHRD / S&P 0.50 / 3.32 | Non-scoringCHRD / S&P CHRD unavailable / $3.08m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.27b |
| 2019-Q11/3 |
LoseCHRD / S&P 9.22% / 13.65% |
WinCHRD / S&P 63.51% / 8.12% |
LoseCHRD / S&P -212.20% / 14.29% |
Non-scoringCHRD / S&P -6.22% / 12.97% | Non-scoringCHRD / S&P CHRD unavailable / 20.86 | Non-scoringCHRD / S&P 0.54 / 3.26 | Non-scoringCHRD / S&P CHRD unavailable / $3.08m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $34.35b |
| 2018-Q40/3 |
LoseCHRD / S&P -61.00% / -13.52% |
LoseCHRD / S&P CHRD unavailable / 9.05% |
LoseCHRD / S&P -117.65% / 18.23% |
Non-scoringCHRD / S&P -1.52% / 13.10% | Non-scoringCHRD / S&P CHRD unavailable / 19.39 | Non-scoringCHRD / S&P 0.47 / 2.94 | Non-scoringCHRD / S&P CHRD unavailable / $3.00m | Non-scoringCHRD / S&P CHRD unavailable / $0.01b | Non-scoringCHRD / S&P CHRD unavailable / $0.00b |
| 2018-Q32/3 |
WinCHRD / S&P 9.33% / 7.71% |
LoseCHRD / S&P CHRD unavailable / 10.21% |
WinCHRD / S&P 25.00% / 19.06% |
Non-scoringCHRD / S&P -6.11% / 13.01% | Non-scoringCHRD / S&P CHRD unavailable / 22.25 | Non-scoringCHRD / S&P 1.29 / 3.45 | Non-scoringCHRD / S&P CHRD unavailable / $3.00m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.17b |
| 2018-Q22/3 |
WinCHRD / S&P 60.12% / 3.43% |
LoseCHRD / S&P CHRD unavailable / 9.03% |
WinCHRD / S&P 172.00% / 14.46% |
Non-scoringCHRD / S&P -13.11% / 12.56% | Non-scoringCHRD / S&P CHRD unavailable / 22.49 | Non-scoringCHRD / S&P 1.20 / 3.25 | Non-scoringCHRD / S&P CHRD unavailable / $3.00m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.19b |
| 2018-Q10/3 |
LoseCHRD / S&P -3.69% / -0.76% |
LoseCHRD / S&P CHRD unavailable / 7.68% |
LoseCHRD / S&P -149.40% / 12.46% |
Non-scoringCHRD / S&P 6.78% / 12.27% | Non-scoringCHRD / S&P 25.56 / 23.41 | Non-scoringCHRD / S&P 0.69 / 3.17 | Non-scoringCHRD / S&P CHRD unavailable / $3.00m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.08b |
| 2017-Q40/3 |
LoseCHRD / S&P -7.79% / 6.64% |
LoseCHRD / S&P CHRD unavailable / 7.03% |
LoseCHRD / S&P -138.35% / 13.82% |
Non-scoringCHRD / S&P CHRD unavailable / 12.09% | Non-scoringCHRD / S&P 18.29 / 24.25 | Non-scoringCHRD / S&P 0.67 / 3.23 | Non-scoringCHRD / S&P CHRD unavailable / $2.92m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.05b |
| 2017-Q31/3 |
WinCHRD / S&P 13.29% / 4.48% |
LoseCHRD / S&P CHRD unavailable / 5.68% |
LoseCHRD / S&P -77.36% / 17.57% |
Non-scoringCHRD / S&P CHRD unavailable / 12.04% | Non-scoringCHRD / S&P CHRD unavailable / 23.28 | Non-scoringCHRD / S&P 0.74 / 3.08 | Non-scoringCHRD / S&P CHRD unavailable / $2.92m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.11b |
| 2017-Q20/3 |
LoseCHRD / S&P -43.55% / 3.09% |
LoseCHRD / S&P CHRD unavailable / 4.83% |
LoseCHRD / S&P -62.69% / 17.74% |
Non-scoringCHRD / S&P CHRD unavailable / 11.96% | Non-scoringCHRD / S&P CHRD unavailable / 23.40 | Non-scoringCHRD / S&P 0.64 / 3.03 | Non-scoringCHRD / S&P CHRD unavailable / $2.92m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.08b |
| 2017-Q11/3 |
LoseCHRD / S&P -5.81% / 6.07% |
LoseCHRD / S&P CHRD unavailable / 3.67% |
WinCHRD / S&P 50.91% / 13.32% |
Non-scoringCHRD / S&P CHRD unavailable / 11.75% | Non-scoringCHRD / S&P CHRD unavailable / 23.60 | Non-scoringCHRD / S&P 1.15 / 3.01 | Non-scoringCHRD / S&P CHRD unavailable / $2.92m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $20.24b |
| 2016-Q42/3 |
WinCHRD / S&P 32.00% / 3.82% |
LoseCHRD / S&P CHRD unavailable / 2.09% |
WinCHRD / S&P 315.62% / 7.05% |
Non-scoringCHRD / S&P CHRD unavailable / 11.37% | Non-scoringCHRD / S&P CHRD unavailable / 23.76 | Non-scoringCHRD / S&P 1.22 / 2.91 | Non-scoringCHRD / S&P CHRD unavailable / $2.88m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $1.11b |
| 2016-Q31/3 |
WinCHRD / S&P 22.81% / 3.85% |
LoseCHRD / S&P CHRD unavailable / 0.20% |
LoseCHRD / S&P -175.71% / -3.15% |
Non-scoringCHRD / S&P CHRD unavailable / 10.82% | Non-scoringCHRD / S&P CHRD unavailable / 24.22 | Non-scoringCHRD / S&P 0.87 / 2.78 | Non-scoringCHRD / S&P CHRD unavailable / $2.88m | Non-scoringCHRD / S&P CHRD unavailable / $0.00b | Non-scoringCHRD / S&P CHRD unavailable / $0.16b |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | CHRD total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 38.58% | 20.78% |
| Annualized return | 38.58% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | CHRD total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 163.40% | 83.14% |
| Annualized return | 21.37% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | CHRD total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 2430.71% | 319.30% |
| Annualized return | 38.14% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
- Net margin, P/E, P/B and other gray context columns never enter the score.
Snapshot captured 2026-09-04.